Europe
United Kingdom
Europe
United Kingdom

A leading independent European specialty pharmaceutical company

Our business strategy

Peter Stein CEO
Peter Stein, CEO

“Our vision is to be the leading European specialty company, operating as a single integrated European team to develop innovative products and improve patients’ lives.”

 

 

Since 1906, Norgine has developed and marketed high quality and innovative products that patients, healthcare professionals and budget holders want and value.

 

We are dedicated to finding solutions through partnering which is core both to our business success and our vision for improving healthcare.

 

We want to continue to build up our position as the leading European Specialty Pharmaceutical company which aims to drive growth, foster innovation and generate revenue, while remaining an attractive place to work.

 

But also, we want to leverage Norgine Ventures, a new complementary business unit which provides debt financing to fast-growing companies in the fields of healthcare and life sciences, in Europe and the US.

 

  

Peter Stein, CEO

 

" Norgine believes that there are attractive opportunities to develop innovative products which not only improve patient care but also can be proven to add economic value to the overall healthcare system."

 

"We are focused on identifying these opportunities and helping to bring them to market,"